Navigation Links
EpiCept Corporation to Present at The New York Society of Security Analysts 11th Annual Biotech & Specialty Pharma Conference
Date:12/5/2007

TARRYTOWN, N.Y., Dec. 5 /PRNewswire-FirstCall/ -- EpiCept Corporation (Nasdaq and OMX Nordic Exchange: EPCT) today announced that Jack Talley, President and CEO, will present a company overview at the New York Society of Security Analysts ("NYSSA") 11th Annual Biotech & Specialty Pharma Conference on December 12, 2007 at 4:05 p.m. Eastern Time. The conference will be held at the NYSSA's headquarters at 1177 Avenue of the Americas in New York City.

(Logo: http://www.newscom.com/cgi-bin/prnh/20020513/NYM112LOGO )

The presentation will be available live via webcast on December 12, 2007. The webcast can be accessed by visiting http://www.epicept.com. A replay of the presentation will be available for 90 days following the event.

About EpiCept Corporation

EpiCept is focused on unmet needs in the treatment of pain and cancer. The Company's broad portfolio of pharmaceutical product candidates includes several pain therapies in clinical development and a lead oncology compound for AML with demonstrated efficacy in a Phase III trial; a marketing authorization application for this compound is approaching a decision in Europe. In addition, EpiCept's ASAP technology, a proprietary live cell high- throughput caspase-3 screening technology, can efficiently identify new cancer drug candidates and molecular targets that selectively induce apoptosis in cancer cells. Two oncology drug candidates currently in clinical development that were discovered using this technology have also been shown to act as vascular disruption agents in a variety of solid tumors.

Forward-Looking Statements

This news release and any oral statements made with respect to the information contained in this news release, contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.
'/>"/>

SOURCE EpiCept Corporation
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. EpiCept Corporation to Present at the 2007 BIO InvestorForum
2. EpiCept to Present Preclinical Studies of EPC2407 in Combination With Anti-Angiogenic and Chemotherpeutic Agents at the AACR-NCI-EORTC International Conference
3. EpiCept Corporation To Present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
4. EpiCept To Host Third Quarter 2007 Conference Call and Webcast on November 7, 2007
5. EpiCept Corporation Reports Third Quarter 2007 Operating and Financial Results
6. EpiCept Corporation to Present at the BMO Capital Markets 2007 Focus on Healthcare Conference
7. Patient Enrollment Completed in Phase IIb Trial of EpiCept(TM) NP-1 in Diabetic Peripheral Neuropathy
8. EpiCept Announces Presentation of New Ceplene(TM) Data at the 49th Annual Meeting of the American Society of Hematology
9. EpiCept Corporation Announces Pricing of Public Offering
10. The ScottCare Corporation Completes Acquisition of Rozinn Electronics, a Leading Manufacturer of Cardiac Diagnostic Products
11. Brooke Franchise Corporation Announces Selected July Results

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)... WHAT: All PETCO stores nationwide will host a...ated by specially trained in-store nutrition, .... During the 30-minute, workshop, pe...f, their dogs and cats, have a chance... nutrition, receive an assessment of their individ...
(Date:11/9/2009)...e University of Florida Proton Therapy Institute h...py for St. Jude patients. The announcement follows...ate the use of proton therapy for rare brain cance...er the clinical protocol, St. Jude will refer pati...erapy Institute in Jacksonville, Fla. The purpose ...
(Date:11/9/2009)... European Urology , the official journal of the E...e entitled ,Are Infertile Men Less Healthy than Fe...urvey, by Dr. Andrea Salonia et al. The conclusion...h a number of medical comorbidities, as objectivel...ity Index. , Dr. Andrea Salonia from the Univers...
(Date:11/9/2009)...try, respiratory disease, often leading to disabil...lic health concern. Studies led by Deborah Young-...l of Construction, have shown that specific types ...the dust that causes these health hazards, yet the...ins very low. , To find out why, Young-Corbett c...
(Date:11/9/2009)...n embryonic stem cell treatment approved by the FD... function in rats with neck spinal cord injuries ...include people with cervical damage. , In Januar...Corp. of Menlo Park, Calif., permission to test th... spinal cord injuries, which occur below the neck....
Breaking Medicine News(10 mins):Health News:St. Jude and UF Proton Therapy Institute to begin proton therapy clinical trial 2Health News:European Urology: Male factor infertility associated with comorbidities 2Health News:Dust control research leads to a NIOSH grant to facilitate adoption of hazard controls 2Health News:Dust control research leads to a NIOSH grant to facilitate adoption of hazard controls 3Health News:UCI embryonic stem cell therapy restores walking ability in rats with neck injuries 2
...ad Effort to Deliver Trusted Clinical Knowledge vi... Elsevier, the leading publisher of scientific,...y that Chris Dillon has joined Elsevier Health,Sci...ing product development, marketing and sales. He w...
...//www.EvasVillage.org ), a comprehensive New Jerse...e in need in 2009, and a decline in foundation gra...n, New Jersey, seeks additional funding to meet th...rams and a decline in foundation grants and gifts...
...ation Management, Inc., now celebrating their 25th...ategic partner for brand strategy and communicatio...H (PRWEB) May 27, 2009 -- Cleveland-based Litigat...tion design, visualizations, online presence, adve...
...16 , , BATTLE CREEK, Mich., May 21 The Interna...announced today that it will deliver its inaugural...d Safety" -- on July 14-16, 2009 at the McCamly Pl...ining to all State, local, tribal and territorial ...
...entral Valley , , MOUNTAIN VIEW, Calif., May 26 ...d leading providers of kidney dialysis services an...nounced their participation at the National Kidney...Satellite Healthcare,s commitment to kidney health...
...ny,s Twelve Nominees , , SAN DIEGO, May 26 Amyl...eminded its shareholders to use their BLUE proxy c...g its two new independent Director nominees: Paul .... , , Amylin,s 2009 Annual Meeting of Stockholder...
Other Medicine News:Health News:Elsevier Appoints Chris Dillon as Managing Director, Clinical Decision Support 2Health News:Elsevier Appoints Chris Dillon as Managing Director, Clinical Decision Support 3Health News:Eva's Village, a Comprehensive New Jersey Anti-Poverty charity, Seeks Additional Funding to Meet the Increasing Need Along with a Decline in Donations 2Health News:Eva's Village, a Comprehensive New Jersey Anti-Poverty charity, Seeks Additional Funding to Meet the Increasing Need Along with a Decline in Donations 3Health News:Eva's Village, a Comprehensive New Jersey Anti-Poverty charity, Seeks Additional Funding to Meet the Increasing Need Along with a Decline in Donations 4Health News:Eva's Village, a Comprehensive New Jersey Anti-Poverty charity, Seeks Additional Funding to Meet the Increasing Need Along with a Decline in Donations 5Health News:Boondock Walker Elevates LMI with Innovative Strategic Communications 2Health News:International Food Protection Training Institute to Deliver Inaugural Training Course to Food Safety Regulators 2Health News:International Food Protection Training Institute to Deliver Inaugural Training Course to Food Safety Regulators 3Health News:Satellite Healthcare Walks for Kidney Health 2Health News:Amylin Advises All Shareholders to Vote Their Blue Proxy Card Today 2Health News:Amylin Advises All Shareholders to Vote Their Blue Proxy Card Today 3Health News:Amylin Advises All Shareholders to Vote Their Blue Proxy Card Today 4
(Date:11/9/2009)...swire-FirstCall/ -- ISTA Pharmaceuticals, Inc. (Na...from the Company,s Bepreve(TM) (bepotastine besila...ies. These results were presented in poster sessi...lege of Allergy, Asthma & Immunology (ACAAI) i... titled, "Treatment of Ocular Itching with Bepotas...
(Date:11/9/2009)... 9 Decision Resources, one of the ...armaceutical and healthcare issues, finds that, in...ER2) targeting therapies -- which include Roche/Ch...,s Tykerb/Tyverb -- were the highest-selling drug ... of Herceptin and Tykerb/Tyverb and the expected l...
(Date:11/9/2009)... Shire plc (LSE: SHP...ceutical company, today announced the availability...Tablets in pharmacies across the United States for...Disorder ( ADHD ) in children and adolescents ag...guanfacine, is the first and only nonscheduled alp...
Breaking Medicine Technology:ISTA Pharmaceuticals Highlights Bepreve(TM) Clinical Data at the 2009 Annual Meeting of the American College of Allergy, Asthma & Immunology (ACAAI) 2ISTA Pharmaceuticals Highlights Bepreve(TM) Clinical Data at the 2009 Annual Meeting of the American College of Allergy, Asthma & Immunology (ACAAI) 3Sales of HER2-Targeting Agents for Breast Cancer, Including Herceptin and Tykerb/Tyverb, Will Grow by 3.3 Percent Annually from 2008 to 2018 2Once-Daily INTUNIV(TM) (guanfacine) Extended Release Tablets Now Available in Pharmacies Nationwide 2Once-Daily INTUNIV(TM) (guanfacine) Extended Release Tablets Now Available in Pharmacies Nationwide 3Once-Daily INTUNIV(TM) (guanfacine) Extended Release Tablets Now Available in Pharmacies Nationwide 4Once-Daily INTUNIV(TM) (guanfacine) Extended Release Tablets Now Available in Pharmacies Nationwide 5Once-Daily INTUNIV(TM) (guanfacine) Extended Release Tablets Now Available in Pharmacies Nationwide 6Once-Daily INTUNIV(TM) (guanfacine) Extended Release Tablets Now Available in Pharmacies Nationwide 7Ex White House Drug Spokesman Urges Double Drug Treatment 3B Bob Weiner and Policy Analyst Zoe Pagonis Highlight Drug Wars Wrong Focus 52806 1Ex White House Drug Spokesman Urges Double Drug Treatment 3B Bob Weiner and Policy Analyst Zoe Pagonis Highlight Drug Wars Wrong Focus 52806 2Iowa Committee Produces Principles for National Efforts to Reform Health Care 52803 1Iowa Committee Produces Principles for National Efforts to Reform Health Care 52803 2Iowa Committee Produces Principles for National Efforts to Reform Health Care 52803 3Mayor Menino Joins The Salvation Army to Celebrate the Groundbreaking of the Kroc Community Center 52800 1Mayor Menino Joins The Salvation Army to Celebrate the Groundbreaking of the Kroc Community Center 52800 2Mayor Menino Joins The Salvation Army to Celebrate the Groundbreaking of the Kroc Community Center 52800 3
...rauma or,noise-induced hearing loss. By any name, ...nent hearing loss. Up to 28 million Americans,have...c trauma is a,significant contributor, reports the...., Acoustic trauma is a product of modern life. O... but recreational noise -- such as loud music --,i...
...nificantly Improve Overall Survival in .... and EMERYVILLE, Calif., Nov. 19 ,Bayer HealthCar...Nasdaq:,ONXX) today announced that the U.S. Food a...mental New Drug Application for Nexavar(R) (sorafe...resectable hepatocellular,carcinoma (HCC), or live...
Other Medicine Technology:Your Hearing May be at Risk, Says Harvard Men's Health Watch 2Nexavar First FDA-Approved Drug Therapy for Liver Cancer 2Nexavar First FDA-Approved Drug Therapy for Liver Cancer 3Nexavar First FDA-Approved Drug Therapy for Liver Cancer 4Nexavar First FDA-Approved Drug Therapy for Liver Cancer 5Nexavar First FDA-Approved Drug Therapy for Liver Cancer 6
TigerStick™
...offers the Flowmaster. It is a new portable digita...studies, where ease of use, simplicity and cost ef...eless uroflowmeter which makes it now very easy to...wmaster anywhere you want and data will be send wi...
UroPass® II Open Tip Ureteral Stents
Classic Open Tip Ureteral Stents
Medicine Products: